Table of Contents

2019-2024 Global Plasma Protein Systems Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Plasma Protein Systems Market Size 2014-2024
  • 2.1.2 Plasma Protein Systems Market Size CAGR by Region
• 2.2 Plasma Protein Systems Segment by Type
  • 2.2.1 Albumin
  • 2.2.2 Immunoglobulin
  • 2.2.3 Coagulation Factor
  • 2.2.4 Others
• 2.3 Plasma Protein Systems Market Size by Type
  • 2.3.1 Global Plasma Protein Systems Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Plasma Protein Systems Market Size Growth Rate by Type (2014-2019)
• 2.4 Plasma Protein Systems Segment by Application
  • 2.4.1 Hemophilia
  • 2.4.2 Primary Immunodeficiency Disorder
  • 2.4.3 Hereditary Angioedema
  • 2.4.4 Others
• 2.5 Plasma Protein Systems Market Size by Application
  • 2.5.1 Global Plasma Protein Systems Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Plasma Protein Systems Market Size Growth Rate by Application (2014-2019)

3 Global Plasma Protein Systems by Players

• 3.1 Global Plasma Protein Systems Market Size Market Share by Players
  • 3.1.1 Global Plasma Protein Systems Market Size by Players (2017-2019)
  • 3.1.2 Global Plasma Protein Systems Market Size Market Share by Players (2017-2019)
• 3.2 Global Plasma Protein Systems Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Plasma Protein Systems by Regions

• 4.1 Plasma Protein Systems Market Size by Regions
• 4.2 Americas Plasma Protein Systems Market Size Growth
• 4.3 APAC Plasma Protein Systems Market Size Growth
• 4.4 Europe Plasma Protein Systems Market Size Growth
• 4.5 Middle East & Africa Plasma Protein Systems Market Size Growth

5 Americas

• 5.1 Americas Plasma Protein Systems Market Size by Countries
• 5.2 Americas Plasma Protein Systems Market Size by Type
• 5.3 Americas Plasma Protein Systems Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Plasma Protein Systems Market Size by Countries
• 6.2 APAC Plasma Protein Systems Market Size by Type
• 6.3 APAC Plasma Protein Systems Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Plasma Protein Systems by Countries
• 7.2 Europe Plasma Protein Systems Market Size by Type
• 7.3 Europe Plasma Protein Systems Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Plasma Protein Systems by Countries
• 8.2 Middle East & Africa Plasma Protein Systems Market Size by Type
• 8.3 Middle East & Africa Plasma Protein Systems Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Plasma Protein Systems Market Forecast

• 10.1 Global Plasma Protein Systems Market Size Forecast (2019-2024)
• 10.2 Global Plasma Protein Systems Forecast by Regions
  • 10.2.1 Global Plasma Protein Systems Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Plasma Protein Systems Forecast by Type
• 10.8 Global Plasma Protein Systems Forecast by Application

11 Key Players Analysis

• 11.1 CSL Plasma
  • 11.1.1 Company Details
  • 11.1.2 Plasma Protein Systems Product Offered
  • 11.1.3 CSL Plasma Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 CSL Plasma News
• 11.2 Grifols
  • 11.2.1 Company Details
  • 11.2.2 Plasma Protein Systems Product Offered
  • 11.2.3 Grifols Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Grifols News
• 11.3 Biotest
  • 11.3.1 Company Details
  • 11.3.2 Plasma Protein Systems Product Offered
  • 11.3.3 Biotest Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Biotest News
• 11.4 Kedrion
  • 11.4.1 Company Details
  • 11.4.2 Plasma Protein Systems Product Offered
  • 11.4.3 Kedrion Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Kedrion News
• 11.5 Kamada
  • 11.5.1 Company Details
  • 11.5.2 Plasma Protein Systems Product Offered
  • 11.5.3 Kamada Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Kamada News
• 11.6 Octapharma
  • 11.6.1 Company Details
  • 11.6.2 Plasma Protein Systems Product Offered
  • 11.6.3 Octapharma Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Octapharma News
• 11.7 China Biologic Products Holdings
  • 11.7.1 Company Details
  • 11.7.2 Plasma Protein Systems Product Offered
  • 11.7.3 China Biologic Products Holdings Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 China Biologic Products Holdings News
• 11.8 Hualan Biological Engineering
  • 11.8.1 Company Details
  • 11.8.2 Plasma Protein Systems Product Offered
  • 11.8.3 Hualan Biological Engineering Plasma Protein Systems Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Hualan Biological Engineering News

12 Research Findings and Conclusion

Plasma protein system is a unique and biologic pathway that are either injected or infused to treat a life-threatening chronic and generic disease including pulmonary disorder, neurologic disorder, bleeding disorder, immune deficiencies, liver cirrhosis, trauma and others.

According to this study, over the next five years the Plasma Protein Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Plasma Protein Systems business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Plasma Protein Systems market by product type, application, key companies and key regions.

This study considers the Plasma Protein Systems value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Albumin
Immunoglobulin
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hemophilia
Primary Immunodeficiency Disorder
Hereditary Angioedema
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Plasma
Grifols
Biotest
Kedrion
Kamada
Octapharma
China Biologic Products Holdings
Hualan Biological Engineering

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Plasma Protein Systems market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Plasma Protein Systems market by identifying its various subsegments.
Focuses on the key global Plasma Protein Systems players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma Protein Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Plasma Protein Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.